Bremazocine: A κ‐Opioid Agonist with Potent Analgesic and Other Pharmacologic Properties
Open Access
- 1 March 2005
- journal article
- review article
- Published by Wiley in CNS Drug Reviews
- Vol. 11 (2) , 195-212
Abstract
Bremazocine is a κ‐opioid receptor agonist with potent analgesic and diuretic activities. As an analgesic it is three‐ to four‐times more potent than morphine, as determined in both hot plate and tail flick tests. Bremazocine and other benzomorphan analogs were synthesized in an effort to produce opiates with greater κ‐opioid receptor selectivity and with minimal morphine‐like side effects. Unlike morphine bremazocine is devoid of physical and psychological dependence liability in animal models and produces little or no respiratory depression. While bremazocine does not produce the characteristic euphoria associated with morphine and its abuse, it has been shown to induce dysphoria, a property that limits its clinical usefulness. Similarly to morphine, repeated administration of bremazocine leads to tolerance to its analgesic effect. It has been demonstrated that the marked diuretic effect of bremazocine is mediated primarily by the central nervous system.Because of its psychotomimetic side effects (disturbance in the perception of space and time, abnormal visual experience, disturbance in body image perception, de‐personalization, de‐realization and loss of self control) bremazocine has limited potential as a clinical analgesic. However, its possible utility for the therapy of alcohol and drug addiction warrants further consideration because of its ability to decrease ethanol and cocaine self‐administration in non‐human primates. In addition, the ability of bremazocine‐like drugs to lower intraocular pressure and to minimize ischemic damage in animal models suggests their possible use in the therapy of glaucoma and cardiovascular disease.Keywords
This publication has 130 references indexed in Scilit:
- Pharmacological Interaction of Opiates with Various Classes of Centrally Acting Dopaminergic DrugsDrug Metabolism and Drug Interactions, 1991
- Vascular effects of some opioid receptor agonistsCanadian Journal of Physiology and Pharmacology, 1991
- EFFECTS OF OPIATES AND OPIOIDS ON INTRAOCULAR PRESSURE OF RABBITS AND HUMANSClinical and Experimental Pharmacology and Physiology, 1985
- Bremazocine induces antinociception, but prevents opioid-induced constipation and catatonia in rats and precipitates withdrawal in morphine-dependent ratsLife Sciences, 1984
- A comparative study of the respiratory depressant and analgesic effects of bremazocine, a κ-agonistLife Sciences, 1983
- Inhibitory effect of a new opioid agonist on reproductive endocrine activity in rats of both sexesLife Sciences, 1983
- Effects of [D-Ala2]-methionine-enkephalin on blood pressure, heart rate, and baroreceptor reflex sensitivity in conscious cats.Hypertension, 1981
- Bremazocine: A potent, long-acting opiate kappa-agonistLife Sciences, 1980
- Enkephalin effects on blood pressure, heart rate, and baroreceptor reflex.Hypertension, 1980
- Effects of naloxone, morphine and methionine enkephalin on serum prolactin, luteinizing hormone, follicle stimulating hormone, thyroid stimulating hormone and growth hormoneLife Sciences, 1977